Jul 7, 2023BDR Pharma launches new drug for Philadelphia chromosome-positive leukemiaBDR Pharmaceuticals on Wednesday announced the launch of Nilotinib for a rare subtype of the most common childhood cancer, acute...
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies